Clinical
Publications
Four peer-reviewed publications have evaluated the Embrace® Hydrogel Embolic System — two clinical studies in patients and two preclinical studies across rat and rabbit models, evaluating use in the embolization of hypervascular tumors.
Peer-reviewed publications
Multicenter Randomized Trial Evaluating the Safety and Effectiveness of the Instylla Hydrogel Embolic System for Vascular Occlusion of Hypervascular Tumors
Abi-Jaoudeh N, Chen J, Dey C, Tahour D, Le T, Novelli P, Charalel R, Nadolski G, St. Amour E. Journal of Vascular and Interventional Radiology. 2026.
A Pilot First-In-Human Study Of Embrace, A Polyethylene Glycol-Based Liquid Embolic Agent, In The Embolization Of Malignant And Benign Hypervascular Tumors
Goh GS, Goodwin MD, Huang JF, Kavnoudias H, Holden A, et al. Journal of Vascular and Interventional Radiology. 2022 Jun;33(6):660–667.
Comparison Of Liquid With Particle Embolics In A Translational Rat Model Of Hepatocellular Carcinoma: Histologic And Radiographic Responses
Gurevich A, Islam A, Wakim J, Yarsky E, Kiefer R, El-Ghazal R, McClung G, Cormode DP, Nadolski GJ, Avritscher R, Hunt SJ, Gade TPF. Journal of Vascular and Interventional Radiology.
A Water-Based Liquid Embolic: Evaluation Of Its Safety And Efficacy In A Rabbit Kidney Model
Ganguli S, Lareau R, Jarrett T, Soulen MC. Journal of Vascular and Interventional Radiology. 2021 Jun;32(6):813–818.
Please refer to the Embrace HES Instructions for Use (IFU) for complete information regarding indications, contraindications, warnings, precautions, and directions for use.